LBA19 GEICAM/2014-12 (FLIPPER) study: First analysis from a...

Annals of Oncology 2020 / 09 Vol. 31

LBA19 GEICAM/2014-12 (FLIPPER) study: First analysis from a randomized phase II trial of fulvestrant (F)/palbociclib (P) versus (vs) F/placebo (PL) as first-line therapy in postmenopausal women with HR (hormone receptor)+/HER2– endocrine sensitive advanced breast cancer (ABC)

Albanell, J., Martinez, M.T.M., Ramos, M., Connor, M.O.', De la Cruz-Merino, L., Santaballa Bertran, A., Martínez-Jáñez, N., Moreno, F., Fernández Pérez, I., Alarcon Company, J., Virizuela Echabu
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
31
Journal:
Annals of Oncology
DOI:
10.1016/j.annonc.2020.08.2247
Date:
September, 2020
File:
PDF, 92 KB
2020
Conversion to is in progress
Conversion to is failed